Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.

  • 2022-02-01
  • Archivos argentinos de pediatria 120(1)
    • Christian Boggio Marzet
    • Fernando Burgos
    • Mónica Del Compare
    • Ingrid Gerold
    • Omar Tabacco
    • Gabriel Vinderola

Study Design

Type
Review
Population
pediatrics
Methods
descriptive review of probiotic use in pediatrics, focused on Lactobacillus rhamnosus GG
Preterm birth, C-sections, antibiotics, and limited breastfeeding contribute to the increase in noncommunicable diseases. Our objective was to perform a descriptive review of probiotic use in pediatrics, focused on Lactobacillus rhamnosus GG. Certain probiotics have demonstrated to be effective in acute diarrhea and antibiotic-associated diarrhea. L. rhamnosus GG and Saccharomyces boulardii may shorten their duration and symptoms. L. reuteri DSM 17938 and L. rhamnosus GG were effective to manage infant colic. The use of this strain in infant formulas for cow's milk protein allergy may promote an earlier tolerance acquisition. In relation to the prevention of atopic dermatitis, the administration of L. rhamnosus GG during pregnancy reduced its development in the infant. The use of probiotics as adjuvants is a possibility to consider in current pediatric practice.

Research Insights

Adverse Events Reported

  • Lactobacillus rhamnosus GGOverall tolerability

    The use of this strain in infant formulas for cow's milk protein allergy may promote an earlier tolerance acquisition.

    Finding
    Reported
  • saccharomyces boulardiiOverall tolerability

    L. rhamnosus GG and Saccharomyces boulardii may shorten their duration and symptoms.

    Finding
    Reported
  • Lactobacillus reuteri DSM 17938Overall tolerability

    L. reuteri DSM 17938 and L. rhamnosus GG were effective to manage infant colic.

    Finding
    Reported
Back to top